Tetanus toxoid-loaded transfersomes for topical immunization

被引:52
作者
Gupta, PN [1 ]
Mishra, V [1 ]
Singh, P [1 ]
Rawat, A [1 ]
Dubey, P [1 ]
Mahor, S [1 ]
Vyas, SP [1 ]
机构
[1] Dr Hari Singh Gour Vishwavidyalaya, Dept Pharmaceut Sci, Drug Delivery Res Lab, Sagar 470003, MP, India
关键词
D O I
10.1211/0022357055515
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Topical immunization is a novel immunization strategy by which antigens and adjuvants are applied topically to intact skin to induce potent antibody and cell-mediated responses. Among various approaches for topical immunization, the vesicular approach is gaining wide attention. Proteineous antigen alone or in combination with conventional bioactive carriers could not penetrate through the intact skin. Hence, specially designed, deformable lipid vesicles called transfersomes were used in this study for the non-invasive delivery of tetanus toxoid (TT). Transfersomes were prepared and characterized for shape, size, entrapment efficiency and deformability index. Fluorescence microscopy was used to investigate the mechanism of vesicle penetration through the skin. The immune stimulating activity of these vesicles was studied by measuring the serum anti-tetanus toxoid IgG titre following topical immunization. The immune response was compared with the same dose of alum adsorbed tetanus toxoid (AATT) given intramuscularly, topically administered plain tetanus toxoid solution, and a physical mixture of tetanus toxoid and transfersomes again given topically. The results indicated that the optimal transfersomal formulation had a soya phosphatidylcholine and sodium deoxycholate ratio of 85:15%, w/w. This formulation showed maximum entrapment efficiency (87.34 +/- 3.81%) and deformability index (121.5 +/- 4.21). An in-vivo study revealed that topically administered tetanus toxoid-loaded transfersomes, after secondary immunization, elicited an immune response (anti-TT-IgG) comparable with that produced by intramuscular AATT. Fluorescence microscopy revealed the penetration of transfersomes through the skin to deliver the antigen to the immunocompetent Langerhans cells.
引用
收藏
页码:295 / 301
页数:7
相关论文
共 31 条
  • [1] THE PREPARATION AND PROPERTIES OF NIOSOMES NON-IONIC SURFACTANT VESICLES
    BAILLIE, AJ
    FLORENCE, AT
    HUME, LR
    MUIRHEAD, GT
    ROGERSON, A
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1985, 37 (12) : 863 - 868
  • [2] THE SKIN IMMUNE-SYSTEM (SIS) - DISTRIBUTION AND IMMUNOPHENOTYPE OF LYMPHOCYTE SUBPOPULATIONS IN NORMAL HUMAN-SKIN
    BOS, JD
    ZONNEVELD, I
    DAS, PK
    KRIEG, SR
    VANDERLOOS, CM
    KAPSENBERG, ML
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 1987, 88 (05) : 569 - 573
  • [3] LIPID VESICLES PENETRATE INTO INTACT SKIN OWING TO THE TRANSDERMAL OSMOTIC GRADIENTS AND HYDRATION FORCE
    CEVC, G
    BLUME, G
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1992, 1104 (01) : 226 - 232
  • [4] Ultraflexible vesicles, transfersomes, have an extremely low pore penetration resistance and transport therapeutic amounts of insulin across the intact mammalian skin
    Cevc, G
    Gebauer, D
    Stieber, J
    Schätzlein, A
    Blume, G
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 1998, 1368 (02): : 201 - 215
  • [5] TRANSDERMAL DRUG CARRIERS - BASIC PROPERTIES, OPTIMIZATION AND TRANSFER EFFICIENCY IN THE CASE OF EPICUTANEOUSLY APPLIED PEPTIDES
    CEVC, G
    SCHATZLEIN, A
    BLUME, G
    [J]. JOURNAL OF CONTROLLED RELEASE, 1995, 36 (1-2) : 3 - 16
  • [6] CEVC G, 1993, HYDRATION BIOL MACRO, P338
  • [7] Adjuvantation of epidermal powder immunization
    Chen, DX
    Erickson, CA
    Endres, RL
    Periwal, SB
    Chu, QL
    Shu, C
    Maa, YF
    Payne, LG
    [J]. VACCINE, 2001, 19 (20-22) : 2908 - 2917
  • [8] DISTRIBUTION OF ATPASE-POSITIVE LANGERHANS CELLS IN NORMAL ADULT HUMAN-SKIN
    CHEN, H
    YUAN, J
    WANG, Y
    SILVERS, WK
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 1985, 113 (06) : 707 - 711
  • [9] CRUZ PD, 1990, DERMATOL CLIN, V8, P633
  • [10] PARAMETERS AFFECTING THE IMMUNOGENICITY OF MICROENCAPSULATED TETANUS TOXOID
    ESPARZA, I
    KISSEL, T
    [J]. VACCINE, 1992, 10 (10) : 714 - 720